• 1
    Williams R. Classification, etiology, and considerations of outcome in liver failure. Semin Liver Dis 1996; 16: 343348.
  • 2
    Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002; 6: 10451066.
  • 3
    Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of IL-18 in inflammatory liver diseases. Immunology 2000; 174: 192209.
  • 4
    Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, et al. Imbalanced intrahepatic expression of IL-12, IFNγ, and IL-10 in fulminant hepatitis B. HEPATOLOGY 2002; 36: 1000111008.
  • 5
    Blei AT. Diagnosis and treatment of hepatic encephalopathy. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 959974.
  • 6
    Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, et al. IL-18 accounts for both TNFα-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159: 39613967.
  • 7
    Chen YL, Yu CK, Lei HY. P. acnes induces acute TNFα-mediated apoptosis of hepatocytes followed by inflammatory T-cell-mediated granulomatous hepatitis in mice. J Biomed Sci 1999; 6: 349356.
  • 8
    Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y, et al. Alleviation of LPS-induced acute liver injury in P. acnes-primed IFNγ-deficient mice by a concomitant reduction of TNFα, IL-12 and IL-18 production. J Immunol 1999; 162: 10491055.
  • 9
    Shimizu Y, Margenthaler JA, Landeros K, Otomo N, Doherty G, Flye MW. The resistance of P. acnes-primed IFNγ-deficient mice to low-dose LPS-induced acute liver injury. HEPATOLOGY 2002; 35: 805814.
  • 10
    Dziarski R, Wang Q, Miyake K, Kirsching CJ, Gupta D. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to LPS and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol 2001; 166: 19381944.
  • 11
    Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667672.
  • 12
    O'Neill LA. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol 2002; 23: 296300.
  • 13
    Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135145.
  • 14
    Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335376.
  • 15
    Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. Endotoxin and cytokine regulation of Toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000; 20: 915921.
  • 16
    Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, et al. Role of Toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002; 70: 34333442.
  • 17
    Shimizu H, Matsuguchi T, Fukuda Y, Nakano I, Hayakawa T, Takeuchi O, et al. Toll-like receptor 2 contributes to liver injury by Salmonella infection through fas ligand expression on NKT cells in mice. Gastroenterology 2002; 123: 12651277.
  • 18
    Riordan S, Skinner N, Nagree A, McCallum H, McIver C, Kurtovic J, et al. Peripheral blood mononuclear cell expression of Toll-like receptors and relation to cytokine levels in cirrhosis. HEPATOLOGY 2003; 37: 11541164.
  • 19
    Paik YH, Schwabe R, Bataller R, Russo M, Jobin C, Brenner D. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. HEPATOLOGY 2003; 37: 10431055.
  • 20
    Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of LPS eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000; 165: 618622.
  • 21
    Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, et al. LPS rapidly traffics to and from the Golgi apparatus with the Toll-like receptor-4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 2002; 277: 4783447843.
  • 22
    Mandrekar P, Catalano D, Szabo G. Inhibition of LPS-mediated NF-κB activation by ethanol in human monocytes. Int Immunol 1999; 11: 17811790.
  • 23
    Perez C, Vandesompele J, Vandenbroucke I, Holtappels G, Spelema F, Gevaert P, et al. Quantitative real time polymerase chain reaction for measurementof IL-5Ra splices isoforms mRNA. BMC Biotechnol 2003; 3: 1722.
  • 24
    Tsutsui H, Kayagaki N, Kuida K, Nakano H, Hayashi N, Takeda K, et al. Caspase-1 independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999; 11: 359367.
  • 25
    Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, Ishimaru T, et al. Induction of macrophage-inflammatory protein-3α gene expression by TNF-dependent NF-κB activation. 2002; 168: 56215628.
  • 26
    Toshima K, Mochida S, Ishikawa K, Matsui A, Arai M, Ogata I, et al. Contribution of CD14 to endotoxin-induced liver injury may depend on types of macrophage activation in rats. Biochem Biophys Res Commun 1998; 246: 731735.
  • 27
    Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-kB signaling pathway components. J Immunol 2003; 170: 508519.
  • 28
    Lehner M, Morath S, Michelsen K, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001; 166: 51615167.
  • 29
    Adib-Conquy M, Cavaillon JM. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 2002; 277: 2792727934.
  • 30
    Merlin T, Woelky-Bruggmann R, Fearns C, Freudenberg M, Landmann R. Expression and role of CD14 in mice sensitized to LPS by Propionibacterium acnes. Eur J Immunol 2002; 32: 761772.
  • 31
    Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate LPS-induced cell activation. J Cell Sci 2002; 115: 26032611.
  • 32
    Mullen GE, Kennedy MN, Visintin A, Mazzoni A, Leifer CA, Davies DR, et al. The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci U S A 2003; 100: 39193924.
  • 33
    Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002; 277: 2043120437.
  • 34
    Tsukamoto H, Takei Y, McClain C, Barve S, Schmidt J, Deaciuc I, et al. How is the liver primed or sensitized for alcoholic liver disease? Alcohol Clin Exp Res 2001; 25: 171S181S.
  • 35
    Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. HEPATOLOGY 2001; 34: 101108.
  • 36
    Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, Limbo A, et al. The role of the liver in response to LPS: experimental and clinical findings. J Endotoxin Res 2002; 8: 319327.
  • 37
    Kim WH, Hing F, Radaeva S, Jaruga B, Fan S, Gao B. STAT1 plays an essential role in LPS/D-glactosamine-induced liver apoptosis and injury. Am J Physiol Gastrointest Liver Physiol 2003; 285: G761G768.
  • 38
    Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 15351541.
  • 39
    Medvedev A, Lentschat A, Wahl L, Golenbock D, Vogel S. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002; 169: 52095216.
  • 40
    Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, et al. Lipoteichoic acid (LTA) of Streptococcus penumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003; 278: 1558715594.
  • 41
    Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C, et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit 2002; 8: 149156.
  • 42
    Iwaki D, Mitsuzawa H, Maurakami S, Sano H, Konishi M, Akino T, et al. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J Biol Chem 2002; 277: 2431524320.
  • 43
    Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 2002; 32: 33373347.
  • 44
    Jacinto R, Hartung T, McCall C, Li L. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 2002; 168: 61366141.
  • 45
    Galanos C, Gumenscheimer M, Muhlradt P, Jirillo E, Freudenberg M. MALP-2, a Mycoplasma lipopeptide with classic endotoxic properties: end of an era of LPS monopoly? J Endotoxin Res 2000; 6: 471476.
  • 46
    Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13: 933940.
  • 47
    Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169: 1014.
  • 48
    Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci U S A 2002; 25: 1376613771.
  • 49
    Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001; 1518: 157161.